A. (Ali) Saber Hosseinabadi, PhD

Postdoctoral researcher

Research

Publications
  1. CRISPR/Cas9: A powerful tool for identification of new targets for cancer treatment

    Liu, B., Saber, A. & Haisma, H. J., 10-Mar-2019, In : Drug Discovery Today.

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. CRISPR/Cas9 for overcoming drug resistance in solid tumors

    Saber, A., Liu, B., Ebrahimi, P. & Haisma, H., 21-Jan-2019, In : Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers

    Wei, J., van der Wekken, A. J., Saber, A., Terpstra, M. M., Schuuring, E., Timens, W., Hiltermann, T. J. N., Groen, H. J. M., van den Berg, A. & Kok, K., 4-Jan-2018, In : Cancers. 10, 1, 12 p., 10.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. All-in-one RNA-based assay to detect therapeutic biomarkers in lung cancer

    Wei, J., Rybczynska, A., van der Wekken, A., Saber, A., Terpstra, M., Schuuring, E., Timens, W., Hiltermann, T., Groen, H., van den Berg, A. & Kok, K., Oct-2017, In : Annals of Oncology. 28, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

View all (16) »

View graph of relations

ID: 429215